What is Charlene Farthing's NPI number?

Charlene Farthing's National Provider Identifier (NPI) is 1679627434, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Charlene Farthing's specialty?

Charlene Farthing is listed in the NPPES registry with a primary specialty of Physician Assistant (Physician Assistants & Advanced Practice Nursing Providers).

Where is Charlene Farthing located?

Charlene Farthing's practice location on file with NPPES is 280 Virginia Ave Ne, Norton, VA 24273-1538.

What is Charlene Farthing's phone number?

The practice phone number listed in the NPPES registry for Charlene Farthing is (276) 365-8071.

Does Charlene Farthing accept Medicare?

Charlene Farthing is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Charlene Farthing's NPI active?

Yes — Charlene Farthing's NPI (1679627434) is active in the NPPES registry as of the last update on 2014-02-26.

IndividualActiveAccepts Medicare

Charlene Farthing, P.A.-C

NPI 1679627434 · Physician Assistant · Norton, VA

Charlene Farthing, P.A.-C is a Physician Assistant provider in Norton, VA (NPI 1679627434).

Provider details

NPI number: 1679627434
Entity type: Individual
Primary specialty: Physician AssistantPhysician Assistants & Advanced Practice Nursing Providers
Credential: P.A.-C
Sex: Female
Sole proprietor: No
License: 0010-003809 (VA)

Practice location

280 Virginia Ave Ne

Suite 106

Norton, VA 24273-1538

Phone: (276) 365-8071

Fax: (949) 862-3723

Street-level locationGet directions

More VA providers

Mailing address

280 Virginia Ave Ne

Norton, VA 24273-1538

Specialties & taxonomies

Physician AssistantPrimary363A00000XLicense 0010-003809 (VA)
Physician Assistants & Advanced Practice Nursing Providers

Enrolled with Medicare as Practitioner - Physician Assistant · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(94/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
19 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
3,629 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,133	$5
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	922	$71
Destruction of Skin Growth, 1-14 Growths17110	443	$84
Destruction of Precancer Skin Growth, 1 Growth17000	430	$37
Biopsy of Related Skin Growth, First Growth11102	212	$63
New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 22 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Clobetasol Propionate	238	134
Ketoconazole	220	142
Triamcinolone Acetonide	180	144
Hydrocortisone	140	97
Mometasone Furoate	96	63
Mupirocin	78	71
Doxycycline Hyclate	76	45
Imiquimod	63	53

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$653 across 30 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2007-01-22
Last updated: 2014-02-26

Frequently asked questions

What is Charlene Farthing's NPI number?: Charlene Farthing's National Provider Identifier (NPI) is 1679627434, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Charlene Farthing's specialty?: Charlene Farthing is listed in the NPPES registry with a primary specialty of Physician Assistant (Physician Assistants & Advanced Practice Nursing Providers).
Where is Charlene Farthing located?: Charlene Farthing's practice location on file with NPPES is 280 Virginia Ave Ne, Norton, VA 24273-1538.
What is Charlene Farthing's phone number?: The practice phone number listed in the NPPES registry for Charlene Farthing is (276) 365-8071.
Does Charlene Farthing accept Medicare?: Charlene Farthing is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Charlene Farthing's NPI active?: Yes — Charlene Farthing's NPI (1679627434) is active in the NPPES registry as of the last update on 2014-02-26.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,133	$5
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	922	$71
Destruction of Skin Growth, 1-14 Growths17110	443	$84
Destruction of Precancer Skin Growth, 1 Growth17000	430	$37
Biopsy of Related Skin Growth, First Growth11102	212	$63
New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More

Drug

Part D claims (2024)

Beneficiaries

Clobetasol Propionate

238

134

Ketoconazole

220

142

Triamcinolone Acetonide

180

144

Hydrocortisone

140

Mometasone Furoate

Mupirocin

Doxycycline Hyclate

Imiquimod

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$653 across 30 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments